Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

New Strong Sell Stocks for Oct. 22


Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Atossa Therapeutics, Inc. ATOS is a clinical-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 4% downward over the last 60 days.

Bridgeline Digital, Inc. BLIN is a marketing technology company. The Zacks Consensus Estimate for its current year earnings has been revised 12% downward over the last 60 days.

Cantaloupe, Inc. CTLP is a digital payment and software services company. The Zacks Consensus Estimate for its current year earnings has been revised 6.7% downward over the last 60 days.

View the entire Zacks Rank #5 List.

Beyond Nvidia: AI's Second Wave Is Here

The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.

See "2nd Wave" AI stocks now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Bridgeline Digital, Inc. (BLIN): Free Stock Analysis Report
 
Atossa Genetics Inc. (ATOS): Free Stock Analysis Report
 
Cantaloupe, Inc. (CTLP): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research


Source Zacks-com

Like: 0
Share
At Zacks, we are dedicated to independent investment research, helping investors succeed through tools like our Zacks Rank stock-rating system, which has averaged +23.89% annual returns since 1988. Founded on the discovery that earnings estimate revisions drive stock prices, we offer purely mathematical, unbiased ratings, along with additional innovations like the Price Response Indicator, Earnings ESP, and specialized rankings for mutual funds and ETFs.
...
Legal notice

Comments